Associate Director
AdvanCell
Associate Director
AdvanCell
Manufactures Lead-212 for targeted alpha therapy
Salary Range: 170000 to 220000 (Currency: USD) (Pay period: per-year-salary)
Responsibilities will include, but not limited to:
AdvanCell develops radiopharmaceuticals for targeted alpha therapy, using Lead-212 and an on-demand Alpha Isotope Generator to produce the isotope daily. Its core product ADVC-001 targets PSMA to treat metastatic castration-resistant prostate cancer, evaluated in the multicenter TheraPb Phase I/II trial, while the company also pipelines other cancer therapies. The approach combines isotope production, drug manufacturing, and clinical development in a vertically integrated model to ensure reliable supply and faster development. Its goal is to speed patient access to radiopharmaceutical treatments by expanding its portfolio through collaborations, including a strategic partnership with Eli Lilly, and advancing clinical trials.
Explore more opportunities at AdvanCell